These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 23234625

  • 1. Prostate specific antigen best practice statement: 2009 update.
    Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P, American Urological Association.
    J Urol; 2013 Jan; 189(1 Suppl):S2-S11. PubMed ID: 23234625
    [Abstract] [Full Text] [Related]

  • 2. Prostate specific antigen best practice statement: 2009 update.
    Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P.
    J Urol; 2009 Nov; 182(5):2232-41. PubMed ID: 19781717
    [Abstract] [Full Text] [Related]

  • 3. Screening for prostate cancer: the current evidence and guidelines controversy.
    Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R.
    Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
    [Abstract] [Full Text] [Related]

  • 4. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
    Lim LS, Sherin K, ACPM Prevention Practice Committee.
    Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
    [Abstract] [Full Text] [Related]

  • 5. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
    Ito K.
    Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
    [Abstract] [Full Text] [Related]

  • 6. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
    Hua LX, Qiao D, Song NH, Feng NH, Yang J, Zhang JX, Chen JG, Zhang W, Sui YG, Wu HF.
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
    [Abstract] [Full Text] [Related]

  • 7. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ, Volk RJ, Cass AR, Spann SJ.
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [Abstract] [Full Text] [Related]

  • 8. Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA).
    Oncology (Williston Park); 2000 Feb; 14(2):267-72, 277-8, 280 passim. PubMed ID: 10736812
    [Abstract] [Full Text] [Related]

  • 9. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
    Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen C, Thrasher JB, Thompson I.
    J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
    [Abstract] [Full Text] [Related]

  • 10. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP, Cohen SJ, Preisser JS, Wofford JL, Shelton BJ, McClatchey MW.
    Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
    [Abstract] [Full Text] [Related]

  • 11. Prostate cancer screening.
    Sikaris K.
    Pathology; 2012 Feb; 44(2):99-109. PubMed ID: 22198258
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
    Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA.
    J Clin Oncol; 2007 Jul 20; 25(21):3076-81. PubMed ID: 17634486
    [Abstract] [Full Text] [Related]

  • 14. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A, Berg CD.
    Gerontology; 2012 Jul 20; 58(4):331-6. PubMed ID: 22343605
    [Abstract] [Full Text] [Related]

  • 15. PSA-based screening for prostate cancer. Too many adverse effects.
    Prescrire Int; 2012 Sep 20; 21(130):215-7. PubMed ID: 23016259
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
    McDowell ME, Occhipinti S, Gardiner RA, Chambers SK.
    BJU Int; 2012 Apr 20; 109 Suppl 3():64-70. PubMed ID: 22458497
    [Abstract] [Full Text] [Related]

  • 18. Baseline prostate-specific antigen testing at a young age.
    Loeb S, Carter HB, Catalona WJ, Moul JW, Schroder FH.
    Eur Urol; 2012 Jan 20; 61(1):1-7. PubMed ID: 21862205
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prostate-specific antigen in clinical practice.
    Loeb S, Catalona WJ.
    Cancer Lett; 2007 Apr 28; 249(1):30-9. PubMed ID: 17258389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.